Mark Cuban on Wednesday condemned a federal agency’s plan to give a pharmaceutical company controlled by a Chinese billionaire exclusive rights to a new liver cancer treatment developed with U.S. government researchers.
The Dallas Mavericks owner, himself a billionaire, told HuffPost the decision “ignored” the need to use taxpayer-funded research in a way that advantages Americans.
“USA inc has got to start operating in the best interests of all of us shareholders,” the “Shark Tank” host wrote in an email, after retweeting a link to a HuffPost report on the licensing plans. “Our taxes should be an investment that expects a financial and social return.”
The National Institutes of Health proposed awarding Salubris Biotherapeutics Inc. exclusive worldwide rights to a portfolio of patents on an antibody drug used to treat liver cancer, according to a notice published Monday in the Federal Register, first reported by HuffPost.
The firm is the Maryland-based arm of Shenzhen Salubris Pharmaceuticals Co., the Chinese drugmaker run by former Shenzhen mayor and billionaire Ye Chenghai, who with his family controls a 66-percent stake in the $5 billion company.
No comments:
Post a Comment